1985
DOI: 10.1016/0022-1759(85)90151-6
|View full text |Cite
|
Sign up to set email alerts
|

Generation of procoagulant activity by mononuclear phagocytes: Optimisation of an in vitro assay

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
5
0

Year Published

1986
1986
2014
2014

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 29 publications
0
5
0
Order By: Relevance
“…In pig artery patch recipients, pro-inflammatory CD14 + CD11c + monocytes were significantly increased with IS, together with significantly higher percentages of activated monocytes and DC and significant upregulation of TF expression (Figure 3). The pro-coagulant properties of innate immune cells are well characterized (51, 52). Activated monocytes and dendritic cells are known to upregulate TF expression, and to mediate inflammation and coagulation (53-55).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In pig artery patch recipients, pro-inflammatory CD14 + CD11c + monocytes were significantly increased with IS, together with significantly higher percentages of activated monocytes and DC and significant upregulation of TF expression (Figure 3). The pro-coagulant properties of innate immune cells are well characterized (51, 52). Activated monocytes and dendritic cells are known to upregulate TF expression, and to mediate inflammation and coagulation (53-55).…”
Section: Discussionmentioning
confidence: 99%
“…). The procoagulant properties of innate immune cells are well characterized . Activated monocytes and dendritic cells are known to upregulate TF expression and to mediate inflammation and coagulation .…”
Section: Discussionmentioning
confidence: 99%
“…The procoagulant ac tivity of the cells was then measured in an automatic coagulometer (Schnitger and Gross, Amelung GmbH, Lemgo, FRG) by mixing 0.2 ml of cell suspension, 0.1 ml of platelet-poor, citrated human plasma and 0.1 ml CaCL (0.025 mol/l). The plasma was prepared and used following the precautions outlined by Geczy and Meyer [6] and by Morrice et al [10], Each test was conducted in triplicate. A standard thromboplastin calibration curve was constructed for each batch of plasma, using serial dilutions of standardised throm boplastin (Manchester comparative reagent, National UK Refer ence Laboratory, Withington Hospital, Manchester).…”
Section: Leucocyte Procoagulant Activitymentioning
confidence: 99%
“…A standard thromboplastin calibration curve was constructed for each batch of plasma, using serial dilutions of standardised throm boplastin (Manchester comparative reagent, National UK Refer ence Laboratory, Withington Hospital, Manchester). The clotting times were expressed in standard thromboplastin units [10],…”
Section: Leucocyte Procoagulant Activitymentioning
confidence: 99%
“…It was stored in 2-ml aliquots at -70 °C for more than 2 months. Im- mediately prior to use, the plasma was thawed at 37 °C for 30 min, followed by 30 min at 4°C to allow stabili zation [12].…”
mentioning
confidence: 99%